Replies to post #662293 on NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

ILT,

It has two dates. Uploaded dates and Public dates.

If it were you, would you make your data public before you were affirmative that your publication had been accepted?

Again, in 10Q on August 9, 2020, specialized vendors and genetic profiles were mentioned. The data from GEO is indeed genetic profiling analysis, which really makes me wonder if specialized vendors mean some divisions of NCI.

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001072379/000110465920092797/nwbo-20200630x10q.htm

As the Company recently reported, this process has been completed and all of the trial sites are now finished. The data from the trial sites comprises most, though not all, of the data required for analyzing the trial. The remaining required data includes information from specialized vendors -- for example, genetic profiles such as IDH mutations. When this external data joins the now locked data from the trial sites, the overall trial dataset will be locked.

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249282